| Literature DB >> 35433418 |
Waseem Masalha1,2, Dieter Henrik Heiland1,2, Christine Steiert1,2, Marie T Krueger1,2,3, Daniel Schnell2,4,5, Christian Scheiwe1,2, Anca-L Grosu2,4,5, Oliver Schnell1,2, Juergen Beck1,2, Juergen Grauvogel1,2.
Abstract
Introduction: Petroclival meningioma (PCM) remains a major neurosurgical challenge. There are still controversial strategic treatment concepts about surgical approach, the extent of resection, and postoperative radiotherapy. We aimed to evaluate prognostic factors influencing the progression-free survival (PFS) rates of PCM, with a particular focus on the retrosigmoidal approach, the role of the extent of resection, and postoperative radiotherapy.Entities:
Keywords: meningioma; petroclival meningioma; postoperative radiotherapy; progression-free survival; surgery
Year: 2022 PMID: 35433418 PMCID: PMC9010819 DOI: 10.3389/fonc.2022.786909
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1(A) Flow diagram of included patients with petroclival meningioma from our database. (B) Flow diagram of the different treatment arms. (C) Kaplan–Meier curve of all patients for progression-free survival based on infiltration of cavernous sinus. (D) Kaplan–Meier curve of all patients for progression-free survival based on extent of resection (GTR vs. STR). (E) Kaplan–Meier curve of all patients for progression-free survival based on therapy (surgery vs. surgery plus radiotherapy).
Patient data.
| Parameter | Surgery | Surgery plus Radiotherapy | |
|---|---|---|---|
| N=58 | N=31 | ||
| Age (median, CI 95%) | 56.5 (39.7–73.2) | 54 (42–68.5) |
|
| Sex (N, %) |
| ||
|
| 50 (86%) | 26 (84%) | |
| | 8 (14%) | 5 (16%) | |
| Resection grade (N, %) |
| ||
| | 18 (31%) | 1 (3%) | |
| | 40 (69%) | 30 (97%) | |
| Preoperative KPS (median, CI 95%) | 80 (70–90) | 80 (70–90) |
|
| Postoperative KPS (median, CI 95%) | 90 (80–100) | 80 (70–100) |
|
| Edema on Brainstem | 19 (32%) | 10 (32%) |
|
| No edema on brainstem | 39 (68%) | 21 (68%) |
|
| Tumor size in cm³ (median, CI 95%) | 10 (4.7–24.7) | 15 (14–39) |
|
| Primary | 50 (86%) | 24 (77%) |
|
| Secondary | 8 (14%) | 7 (23%) |
|
| Compression of brainstem | 51 (88%) | 29 (94%) |
|
| No compression of brainstem | 7 (12%) | 2 (6%) |
|
*Wilcoxon test.
**Fisher,s exact test.
***Chi-squared test.
KPS, Karnofsky Performance scale; CI, confidence interval; GTR, gross total resection; STR, subtotal resection.
Postoperative cranial nerve deficits of patients who underwent surgery.
| Postoperative cranial nerve deficits | Early (N, %) | Permanent (N, %) |
|---|---|---|
| II c.n | 1 (1.1%) | 1 (1.1%) |
| III c.n | 10 (11.2%) | 6 (6.7%) |
| IV c.n | 4 (4.4%) | 1 (1.1%) |
| V c.n | 10 (11.2%) | 5 (5.6%) |
| VI c.n | 15 (16.8%) | 7 (7.8%) |
| VII c.n | 17 (19.1%) | 9 (10.1%) |
| VIII c.n | 17 (19.1%) | 6 (6.7%) |
| IX c.n | 2 (2.2%) | 0 (0%) |
| X c.n | 2 (2.2%) | 1 (1.1%) |
| XI c.n | 2 (2.2%) | 2 (2.2%) |
| XII c.n | 1 (1.1%) | 1 (1.1%) |
c.n, ranial nerve.
Cox-regression analysis of all patients.
| Variable clinical and treatment factors | Progression-free survival | Progression-free survival | ||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Univariate analysis | Multivariate analysis | |||
|
| 0.42 (0.18–0.99) |
| 0.33 (0.12–0.92) |
|
|
| 0.34 (0.15–0.78) |
| 0.28 (0.11–0.69) |
|
|
| 4 (1.3–12) |
| 4.5 (1.04–19.4) |
|
|
| 2.9 (1.1–7.1) |
| 7 (2.42–20.3) |
|
|
| 0.84 (0.34–2.1) | 0.7 | ||
|
| 0.31(0.12–0.76) |
| 0.52 (0.17–1.5) | 0.25 |
|
| 0.34 (0.14–0.79) |
| 0,58 (0.2–1.6) | 0.3 |
|
| 0.46 (0.22–0.97) |
| 0.6 (0.26–1.3) | 0.22 |
|
| 0.64 (0.22–1.9) | 0.42 | ||
|
| 1.8 (0.61–5.2) | 0.29 | ||
|
| 1.7 (0.79–3.7) | 0.17 | ||
GTR, gross total resection; STR, subtotal resection; CI, confidence interval; HR, hazard ratio; KPS, Karnofsky Performance scale.fi 2.
Figure 2(A) Kaplan–Meier curve of patients with PCM with infiltration of the cavernous sinus for progression-free survival based on extent of resection (NTR vs. STR). (B) Kaplan–Meier curve of patients with PCM with infiltration of the cavernous sinus for progression-free survival based on therapy (surgery vs. surgery plus radiotherapy). (C) Kaplan–Meier curve of patients PCM without infiltration of the cavernous sinus for progression-free survival based on extent of resection (GTR vs. STR).
Cox-regression analysis of patient with infiltration of cavernous sinus.
| Variable clinical and treatment factors | Progression-free survival | Progression-free survival | ||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Univariate analysis | Multivariate analysis | |||
|
| 0.39 (0.16–0.97) |
| 0.41 (0.15–1.08) | 0.07 |
|
| 0.54 (0.23–1.3) | 0.17 | ||
|
| 3.9 (1.7–9.2) |
| 5.2 (1.9–13.7) |
|
|
| 3.1(1.2–7.9) |
| 4.8 (1.6–14.3) |
|
|
| 1.7 (0.49–5.7) | 0.41 | ||
|
| 0.39 (0.16–0.98) |
| 1.5 (0.44–5) | 0.52 |
|
| 0.37 (0.15–0.94) |
| 0.53 (0.16–1.7) | 0.3 |
|
| 0.69 (0.29–1.6) | 0.4 | ||
|
| 2.4 (0.69–8.2) | 0.17 | ||
|
| 1.3 (0.57–3.1) | 0.5 | ||
GTR, gross total resection; NTR, near total resection; CI, confidence interval; HR, hazard ratio.